Macrophage mannose receptor-specific gene delivery vehicle for macrophage engineering
Source abstract
Abstract
Macrophages are the most plastic cells in the hematopoietic system and they exhibit great functional diversity. They have been extensively applied in anti-inflammatory, anti-fibrotic and anti-cancer therapies. However, the application of macrophages is limited by the efficiency of their engineering. The macrophage mannose receptor (MMR, CD206), a C-type lectin receptor, is ubiquitously expressed on macrophages and has a high affinity for mannose oligosaccharides. In the present study, we developed a novel non-viral vehicle with specific affinity for MMR. Mannan was cationized with spermine at a grafted ratio of ∼12% to deliver DNA and was characterized as a stable system for delivery. This spermine-mannan (SM)-based delivery system was evaluated as a biocompatible vehicle with superior transfection efficiency on murine macrophages, up to 28.5-fold higher than spermine-pullulan, 11.5-fold higher than polyethylenimine and 3.0-fold higher than Lipofectamine™ 2000. We confirmed that the SM-based delivery system for macrophages transfection was MMR-specific and we described the intracellular transport of the delivery system. To our knowledge, this is the first study using SM to demonstrate a mannose receptor-specific gene delivery system, thereby highlighting the potential of a novel specific non-viral delivery vehicle for macrophage engineering.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Phagocytosis and Immune Regulation · Virus-based gene therapy research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (50)
Show source-provided references
1. Macrophage biology in development, homeostasis and disease10.1038/nature12034 ↗
2. Macrophage regulation of tumor responses to anticancer therapies10.1016/j.ccr.2013.02.013 ↗
3. Macrophages in gene therapy: cellular delivery vehicles and in vivo targets10.1189/jlb.72.3.417 ↗
4. In vivo correction of genetic defects of monocyte/macrophages using attenuated Salmonella as oral vectors for targeted gene delivery10.1038/sj.gt.3301290 ↗
5. Eukaryotic expression plasmid transfer from the intracellular bacterium Listeria monocytogenes to host cells10.1046/j.1462-5822.2001.00138.x ↗
6. Transfection of human immunodeficiency virus type 1 proviral DNA into primary human monocytes10.1006/cimm.1993.1098 ↗
7. Transfection of myelomonocytic cell lines: cellular response to a lipid-based reagent and electroporation10.1006/abio.1999.4024 ↗
8. Therapeutic gene modified cell based cancer vaccines10.1016/j.gene.2013.03.056 ↗
9. The expression of exogenous genes in macrophages: obstacles and opportunities10.1007/978-1-59745-396-7_9 ↗
10. Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA10.4049/jimmunol.168.1.411 ↗
11. Receptor-mediated gene transfer into macrophages10.1073/pnas.93.1.101 ↗
12. Transfection of human macrophages by lipoplexes via the combined use of transferrin and pH-sensitive peptides10.1002/jlb.65.2.270 ↗
13. Ligand recognition by antigen-presenting cell C-type lectin receptors10.1016/j.coi.2004.12.001 ↗
14. C-type lectin receptors on dendritic cells and Langerhans cells10.1038/nri723 ↗
15. The mannose receptor10.1189/jlb.0512231 ↗
16. Structure of a C-type carbohydrate recognition domain from the macrophage mannose receptor10.1074/jbc.M002366200 ↗
17. A long-lasting dendritic cell DNA vaccination system using lysinylated amphiphiles with mannose-mimicking head-groups10.1016/j.biomaterials.2012.05.006 ↗
18. Enhanced transfection efficiency into macrophages and dendritic cells by a combination method using mannosylated lipoplexes and bubble liposomes with ultrasound exposure10.1089/hum.2009.106 ↗
19. Mannosylated chitosan-graft-polyethylenimine as a gene carrier for Raw 264.7 cell targeting10.1016/j.ijpharm.2009.03.033 ↗
20. PET imaging of tumor associated macrophages using mannose coated 64Cu liposomes10.1016/j.biomaterials.2012.07.022 ↗
21. Recent developments in carbohydrate-decorated targeted drug/gene delivery10.1002/med.20171 ↗
22. Mannosyl-coated nanocomplexes from amphiphilic cyclodextrins and pDNA for site-specific gene delivery10.1016/j.biomaterials.2011.06.025 ↗
23. Identification of two Saccharomyces cerevisiae cell wall mannan chemotypes10.1128/JB.111.3.690-695.1972 ↗
24. Effect of amine type on the expression of plasmid DNA by cationized dextran10.1163/156856209X415549 ↗
25. Gene-carried chitosan-linked-PEI induced high gene transfection efficiency with low toxicity and significant tumor-suppressive activity10.1016/j.ijpharm.2009.12.033 ↗
26. Gene recombinant bone marrow mesenchymal stem cells as a tumor-targeted suicide gene delivery vehicle in pulmonary metastasis therapy using non-viral transfection10.1016/j.nano.2013.06.003 ↗
27. N/P ratio significantly influences the transfection efficiency and cytotoxicity of a polyethylenimine/chitosan/DNA complex10.1248/bpb.32.706 ↗
28. Mannosylated biodegradable polyethyleneimine for targeted DNA delivery to dendritic cells10.2147/IJN.S31760 ↗
29. Polyethylenimine-mediated cellular uptake, nucleus trafficking and expression of cytokine plasmid DNA10.1038/sj.gt.3301735 ↗
30. The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls10.1038/mt.2009.281 ↗
31. Tethering functional ligands onto shell of ultrasound active polymeric microbubbles10.1021/bm050723g ↗
32. Polyethylenimine-based non-viral gene delivery systems10.1016/j.ejpb.2004.11.011 ↗
33. Membrane and nuclear permeabilization by polymeric pDNA vehicles: efficient method for gene delivery or mechanism of cytotoxicity?10.1021/mp200368p ↗
34. Tumor-associated macrophages promote angiogenesis and melanoma growth via adrenomedullin in a paracrine and autocrine manner10.1158/1078-0432.CCR-11-1354 ↗
35. CD205 (DEC-205): a recognition receptor for apoptotic and necrotic self10.1016/j.molimm.2008.11.016 ↗
36. Kruppel-like factor 4 regulates macrophage polarization10.1172/JCI45444 ↗
37. Variable antigen uptake due to different expression of the macrophage mannose receptor by dendritic cells in various inbred mouse strains10.1111/j.1365-2567.2008.02960.x ↗
38. Altered expression and endocytic function of CD205 in human dendritic cells, and detection of a CD205-DCL-1 fusion protein upon dendritic cell maturation10.1111/j.1365-2567.2006.02512.x ↗
39. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses10.1016/S0092-8674(00)80693-5 ↗
40. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR10.1126/science.1066371 ↗
41. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation10.1016/j.molimm.2009.09.026 ↗
42. Co-transfection gene delivery of dendritic cells induced effective lymph node targeting and anti-tumor vaccination10.1007/s11095-013-0985-8 ↗
43. A novel cationic liposome formulation for efficient gene delivery via a pulmonary route10.1088/0957-4484/22/24/245104 ↗
44. Understanding biophysicochemical interactions at the nano-bio interface10.1038/nmat2442 ↗
45. Regulated portals of entry into the cell10.1038/nature01451 ↗
46. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials10.1002/smll.201100001 ↗
47. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling10.1083/jcb.200908086 ↗
48. Cellular uptake of cationic polymer–DNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 cells10.1007/s11095-007-9287-3 ↗
49. Cell cycle dependent transcription, a determinant factor of heterogeneity in cationic lipid-mediated transgene expression10.1002/jgm.1010 ↗
50. Barriers to non-viral vector-mediated gene delivery in the nervous system10.1007/s11095-010-0364-7 ↗